Principal neutralizing domain of HIV-1 is highly immunogenic when expressed on the surface of hepatitis B core particles (Q72092275)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7689283%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

title

Principal neutralizing domain of HIV-1 is highly immunogenic when expressed on the surface of hepatitis B core particles (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7689283%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

1 reference

A. von Brunn

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7689283

20 August 2024

M. Brand

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7689283

20 August 2024

C. Reichhuber

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7689283

20 August 2024

C. Morys-Wortmann

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7689283

20 August 2024

F. Deinhardt

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7689283

20 August 2024

F. Schödel

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7689283

20 August 2024

language of work or name

English

0 references

publication date

1 January 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7689283%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

23 October 2019

https://api.elsevier.com/content/article/PII:0264410X93903563?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0264-410X(93)90356-3

https://api.elsevier.com/content/article/PII:0264410X93903563?httpAccept=text/plain

20 August 2024

1 reference

https://api.crossref.org/works/10.1016/0264-410X(93)90356-3

20 August 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7689283%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7689283%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7689283%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

page(s)

817-824

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7689283%20AND%20SRC:MED&resulttype=core&format=json

Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees

23 October 2019

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0264-410X(93)90356-3

Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides

20 August 2024

3

1 reference

https://api.crossref.org/works/10.1016/0264-410X(93)90356-3

Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein

20 August 2024

4

1 reference

https://api.crossref.org/works/10.1016/0264-410X(93)90356-3

Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant

20 August 2024

5

1 reference

https://api.crossref.org/works/10.1016/0264-410X(93)90356-3

A single amino acid interchange yields reciprocal CTL specificities for HIV-1 gp160

20 August 2024

7

1 reference

https://api.crossref.org/works/10.1016/0264-410X(93)90356-3

Human monoclonal antibody that recognizes the V3 region of human immunodeficiency virus gp120 and neutralizes the human T-lymphotropic virus type IIIMN strain

20 August 2024

10

1 reference

https://api.crossref.org/works/10.1016/0264-410X(93)90356-3

Functional contribution of cysteine residues to the human immunodeficiency virus type 1 envelope

20 August 2024

12

1 reference

https://api.crossref.org/works/10.1016/0264-410X(93)90356-3

Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene

20 August 2024

13

1 reference

https://api.crossref.org/works/10.1016/0264-410X(93)90356-3

Identification of a determinant within the human immunodeficiency virus 1 surface envelope glycoprotein critical for productive infection of primary monocytes

20 August 2024

14

1 reference

https://api.crossref.org/works/10.1016/0264-410X(93)90356-3

Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1.

20 August 2024

15

1 reference

https://api.crossref.org/works/10.1016/0264-410X(93)90356-3

Alteration of HIV-1 infectivity and neutralization by a single amino acid replacement in the V3 loop domain

20 August 2024

16

1 reference

https://api.crossref.org/works/10.1016/0264-410X(93)90356-3

Vertical transmission of human immunodeficiency virus is correlated with the absence of high-affinity/avidity maternal antibodies to the gp120 principal neutralizing domain

20 August 2024

18

1 reference

https://api.crossref.org/works/10.1016/0264-410X(93)90356-3

Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160.

20 August 2024

19

1 reference

https://api.crossref.org/works/10.1016/0264-410X(93)90356-3

Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus

20 August 2024

20

1 reference

https://api.crossref.org/works/10.1016/0264-410X(93)90356-3

Broadly neutralizing antibodies elicited by the hypervariable neutralizing determinant of HIV-1.

20 August 2024

21

1 reference

https://api.crossref.org/works/10.1016/0264-410X(93)90356-3

Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site

20 August 2024

22

1 reference

https://api.crossref.org/works/10.1016/0264-410X(93)90356-3

Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein

20 August 2024

24

1 reference

https://api.crossref.org/works/10.1016/0264-410X(93)90356-3

Immunogenicity of peptide fusions to hepatitis B virus core antigen

20 August 2024

26

1 reference

https://api.crossref.org/works/10.1016/0264-410X(93)90356-3

Recombinant core particles of hepatitis B virus exposing foreign antigenic determinants on their surface

20 August 2024

27

1 reference

https://api.crossref.org/works/10.1016/0264-410X(93)90356-3

The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity

20 August 2024

32

1 reference

https://api.crossref.org/works/10.1016/0264-410X(93)90356-3

A conserved region at the COOH terminus of human immunodeficiency virus gp120 envelope protein contains an immunodominant epitope

20 August 2024

33

1 reference

https://api.crossref.org/works/10.1016/0264-410X(93)90356-3

Epitopes of the human malaria parasite P. falciparum carried on the surface of HBsAg particles elicit an immune response against the parasite

20 August 2024

38

1 reference

https://api.crossref.org/works/10.1016/0264-410X(93)90356-3

Long-term high-titer neutralizing activity induced by octameric synthetic HIV-1 antigen

20 August 2024

39

1 reference

https://api.crossref.org/works/10.1016/0264-410X(93)90356-3

20 August 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7689283%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

1 reference